Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Biotransformation of [14C]Vicagrel in Healthy Volunteers
NCT04143750Phase 1Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vicagrel in acute coronary syndrome (ACS) and thrombosis, sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Total radioactive datas in blood, Total radioactive datas in excreta and 6 more. Started Nov 2019; status: completed.
02
Drugs
vicagrel
03
Conditions
acute coronary syndrome (ACS)thrombosis
Beyond the preview
Go deeper on NCT04143750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143750.